| Date Filed | Type | Description |
| 10/02/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 5,797 shares
@ $0 |
|
| 07/06/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 35,634 shares
@ $0 |
|
| 05/31/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP|
Txns:
| Granted 5,357 shares
@ $0
Granted 22,500 options to buy
@ $11.2, valued at
$252k
|
|
| 04/04/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 34,925 shares
@ $0 |
|
| 03/13/2023 |
4
| Myers Scott Dunseth (CEO) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Bought 5,500 shares
@ $29.1499, valued at
$160.3k
|
|
| 02/07/2023 |
4
| Myers Scott Dunseth (CEO) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 250,000 shares
@ $0
Granted 1,000,000 options to buy
@ $35.8, valued at
$35.8M
|
|
| 02/07/2023 |
3
| Myers Scott Dunseth (CEO) has filed a Form 3 on Viridian Therapeutics, Inc.\DE |
| 01/04/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 87,500 options to buy
@ $1.13, valued at
$98.9k
|
|
| 06/24/2022 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 20,334 options to buy
@ $2.01, valued at
$40.9k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 40,000 options to buy
@ $3.31, valued at
$132.4k
|
|
| 11/19/2021 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Trillium Therapeutics Inc.|
Txns:
| Disposed/sold 67,000 options to buy
@ $9.51, valued at
$637.2k
|
|
| 10/26/2021 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $6.31, valued at
$64.2k
|
|
| 10/21/2021 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP|
Txns:
| Granted 10,714 restricted stock units
@ $0
Granted 45,000 options to buy
@ $17.55, valued at
$789.8k
|
|
| 10/21/2021 |
3
| Myers Scott Dunseth (Director) has filed a Form 3 on DYNAVAX TECHNOLOGIES CORP |
| 05/14/2021 |
4/A
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $0 |
|
| 05/07/2021 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $22.5, valued at
$228.8k
|
|
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2020 |
4
| Myers Scott Dunseth (President & CEO) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 1,000,000 options to buy
@ $0 |
|
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $20.59, valued at
$209.3k
|
|
| 04/30/2020 |
4
| Myers Scott Dunseth (President & CEO) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Granted 1,000,000 options to buy
@ $8.2, valued at
$8.2M
|
|
| 04/30/2020 |
3
| Myers Scott Dunseth (President & CEO) has filed a Form 3 on AMAG PHARMACEUTICALS, INC. |
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2019 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 41,436 shares
@ $1.81, valued at
$75k
|
|
| 06/18/2019 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 20,000 options to buy
@ $2.1, valued at
$42k
|
|
| 06/18/2019 |
3
| Myers Scott Dunseth (Director) has filed a Form 3 on SELECTA BIOSCIENCES INC |
| 06/05/2019 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $11.84, valued at
$120.4k
|
|
| 02/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/13/2018 |
4
| Myers Scott Dunseth (President and CEO) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 56,787 shares
@ $0
Disposed/sold 474,810 options to buy
@ $7.08, valued at
$3.4M
Disposed/sold 190,000 options to buy
@ $4.64, valued at
$881.6k
Disposed/sold 60,000 options to buy
@ $3.99, valued at
$239.4k
Disposed/sold 42,000 restricted stock units
@ $0
Disposed/sold 15,500 restricted stock units
@ $0
Disposed/sold 6,300 restricted stock units
@ $0
Disposed/sold 250,000 restricted stock units
@ $0 |
|
| 02/02/2018 |
4
| Myers Scott Dunseth (President and CEO) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0 |
|
| 01/16/2018 |
4
| Myers Scott Dunseth (President and CEO) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,429 shares
@ $3.92, valued at
$13.4k
Exercised 10,500 options to buy
@ $0 |
|
|